Genetic testing for CCD is not yet widely available outside research studies. Commercial testing that includes analysis of the entire RYR1 gene is available at:
The company requests that it be contacted only by health care providers, such as a personal physician.
DNA testing for malignant hyperthermia susceptibility (MHS) is somewhat more widely available. In addition to Prevention Genetics, genetic testing for MHS is available at two locations:
University of Pittsburgh Medical Center
Division of Molecular Diagnostics
Toronto Medical Laboratories
Both these laboratories request that they be contacted only by health care providers.